BOLT logo

Bolt Biotherapeutics, Inc.

BOLT
0.00
USD
+0.00+0.00%

Bolt Biotherapeutics, Inc. at a glance

Open BOLT on Vela

Bolt Biotherapeutics, Inc. (BOLT) is a Healthcare company in the Biotechnology industry, headquartered in Redwood City, CA, with about 23 employees. Its shares trade on NASDAQ, and its IPO date is February 5, 2021. With a market capitalization of $12.1 million, BOLT is a small-cap stock.

It trades an average of 170,273 shares a day.

In its latest reported quarter (results released August 11, 2026), Bolt Biotherapeutics, Inc. posted revenue of $5,000 and earnings of -$4.57 per share, against estimates of $500,000 and -$3.39.

Figures as of October 26, 2026, from market data providers. Descriptive only, not financial advice.

BOLT: Frequently asked questions

As of October 26, 2026, Bolt Biotherapeutics, Inc. has a market capitalization of $12.1 million, making it a small-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.